Stelo: Personalizing Choices, Revolutionizing Glucose Health

Watch the recording of Dr. Thomas Grace, MD, CDCES, as he presents Stelo: Personalizing Choices, Revolutionizing Glucose Health.

About the Webinar

In this 49-minute session, Dr. Thomas Grace explores the groundbreaking features of Stelo, the first FDA-cleared OTC glucose biosensor. Tailored for patients with prediabetes or type 2 diabetes not on insulin, Stelo empowers patients to track their glucose health with ease.

Key Highlights:

• [01:42 - 11:11] The Dexcom portfolio: Glucose management solutions for all stages of the diabetes journey
• [11:12 - 17:15] Why glucose management matters: Understand the impact of a glucose sensor on glycemic outcomes
• [17:16 -21:07]  Introducing Stelo: Explore the innovative functionality of Stelo
• [21:08 - 46:53] Behavior change: See how Stelo can empower people to achieve and maintain health behaviors
• [46:54 - 48:04] Getting started: Learn how to get started on Stelo

About Stelo by Dexcom

Stelo marks a significant advancement in glucose monitoring. As the first FDA-cleared OTC glucose biosensor, it provides an option for those who do not have insurance coverage for CGM.  With Stelo, patients can monitor their glucose levels and target range, enabling informed decisions about their health and lifestyle.

Learn More About Stelo

Don’t miss out on this valuable opportunity to enhance your practice and improve patient care. Learn more at Stelo.com.
 

^{Keywords: Stelo, glucose biosensor, glucose monitoring, prediabetes, type 2 diabetes, Dexcom, patient empowerment, primary care, glucose health webinar}